Submitted by Anonymous (not verified) on 6 November 2023 - 12:55
Human medicines European public assessment report (EPAR): Mozobil, plerixafor, Multiple Myeloma;Hematopoietic Stem Cell Transplantation;Lymphoma, Date of authorisation: 30/07/2009, Revision: 23, Status: Authorised
Source:
